Skip to main content

Vaxcyte, Inc 10-K for FY2023

Vaxcyte, Inc. (PCVX)

10-K 2024-02-27 For: 2023-12-31
View Original
Added on April 07, 2026

About this 10-K

Vaxcyte, Inc filed this 10-K on February 27, 2024, covering the fiscal year ended December 31, 2023 (FY2023).

Headline figures

Fiscal year ended December 31, 2023, as reported in this filing, compared with the same period a year earlier where the filing states it.

Net loss
$402.27M
compared with a net loss of $223.49M a year earlier
Diluted EPS
-$4.14
compared with -$3.44 a year earlier